Stealth BioTherapeutics
Rebranded from Stealth BioTherapeutics to Mighty Therapeutics. Focuses on development of therapies that target mitochondrial dysfunction and positions itself in the field of mitochondrial medicine.
Industries
Biopharma
Biotechnology
Pharmaceutical
Therapeutics
Nr. of Employees
medium (51-250)
Patents
Methods and compositions for detecting and diagnosing diseases and conditions
US-12297502-B2
View DetailsMethods and compositions for the prevention or treatment of Barth Syndrome
US-12268724-B2
View Details
Methods and compositions for detecting and diagnosing diseases and conditions
US-12297502-B2
View DetailsMethods and compositions for the prevention or treatment of Barth Syndrome
US-12268724-B2
View DetailsExpertise Areas
- Mitochondrial medicine
- Therapeutic development for mitochondrial dysfunction
Key Technologies
- Mitochondrial-targeted therapeutic approaches
- Drug/therapeutic development
News & Updates
Announcement that Stealth BioTherapeutics has rebranded as Mighty Therapeutics and directs visitors to the new website. States a continued commitment to advancing therapies that target mitochondrial dysfunction.
Announcement that Stealth BioTherapeutics has rebranded as Mighty Therapeutics and directs visitors to the new website. States a continued commitment to advancing therapies that target mitochondrial dysfunction.